Week 1 HW: Final Project Ideas

BioFit — Grown-to-Shape Bacterial Cellulose Prosthetics/orthotics Interface

1. What would I like to biomanufacture, and why?

I want to biomanufacture a custom-fitted bacterial-cellulose inner interface for lower-limb prosthetic sockets/ knee braces and potentially other wearable orthopedic devices. Instead of manufacturing a flat sheet of material and then cutting, joining, stretching, or thermoforming it around the residual limb, the material would be grown directly around a digitally fabricated 3D former derived from the user’s residual-limb scan. The result would be a seamless, body-specific cellulose structure whose thickness, surface texture, porosity, and geometry could potentially be varied across different regions of the limb. This interests me primarily from a product-design and human-factors perspective. The interface between the residual limb and prosthetic socket is extremely demanding: it experiences pressure, shear, friction, heat, and moisture. These conditions contribute to irritation, blisters, dermatitis, pressure injuries and other skin problems. Heat and perspiration are also significant problems; a literature review found that more than 53% of people with amputations in the included studies experienced heat and/or perspiration discomfort inside their prostheses. . Not just from comfort but even from a functionality point of view , one of the most notable problems related to knee braces is brace migration and that clubs in with interface pressure, thermal comfort, airflow etc . Conventional silicon liners or EVA foam provide cushioning and suspension, but they can also trap heat and perspiration. Research on perforated liners suggests that deliberately controlling moisture pathways can improve residual-limb conditions. (PubMed) Orthopedic wearables have a difficult design problem: the device needs to apply forces to the body, but the interface needs to remain comfortable while doing so. For example, a knee brace may need to apply localized pressure to control movement or unload a joint, while simultaneously avoiding excessive pressure, friction, heat and discomfort. Similarly, prosthetic sockets have to transfer loads between a rigid device and soft biological tissue. That creates an interesting design opportunity for bacterial cellulose because I could potentially spatially engineer the material rather than treating the entire interface as one uniform piece..

Bacterial cellulose forms an interconnected nanofibrillar network and has high water-holding capacity, flexibility, microporosity, and useful mechanical properties. These characteristics have already led to extensive research into wound dressings and other biomedical applications.

My idea therefore is:

“Can I turn the geometry of a person’s body into the geometry of the biological manufacturing environment, so that bacteria grow the interface into its final form?”

2. What living system would I use?

Chassis: Komagataeibacter xylinus ( ko-ma-ga-ta-ee-BAK-ter ZY-li-nus)

I would use Komagataeibacter xylinus as the primary biological manufacturing chassis. K. xylinus is a bacterium well known for producing bacterial cellulose (BC) extracellularly. In a typical process, the bacteria are supplied with a carbon source such as glucose along with nutrients, water, and oxygen. They convert the carbon source through their metabolism and synthesize cellulose nanofibers outside the cells, which assemble into a dense, interconnected cellulose network.

At the simplest level: Input Sugar/glucose + nutrients + water + oxygen + K. xylinus ↓ Biological process Bacteria metabolize the carbon source and synthesize cellulose → nanoscale cellulose fibrils assemble into a hydrated network ↓ Output A hydrated bacterial-cellulose structure BC is especially interesting because the material is extremely water-rich during production standard static fermentation can produce pellicles in which cellulose represents less than 2% of the wet mass.

For BioFit, I would modify the conventional production process by introducing a custom 3D cultivation former. Instead of allowing the bacteria to produce a flat bacterial-cellulose pellicle, I would create a former based on a 3D scan of the user’s anatomy. The former would represent the desired inner surface of a knee-brace interface or prosthetic socket interface. The bacterial culture would then be introduced into a controlled cultivation chamber around the former, with the goal of allowing cellulose to accumulate and conform to its geometry. The process would therefore become: 2.1. 3D scan of user 2.2. Parametric CAD model of interface 2.3. 3D-printed/custom moulded cultivation former 2.4. Inoculation with K. xylinus 2.5. Controlled cellulose growth 2.6. 3D bacterial-cellulose interface 2.7. Washing + purification + conditioning 2.8. Integration into prosthetic/orthotic device

The exact way that BC would grow on a complex 3D former is one of the major uncertainties in my proposal. Most established static BC production forms a pellicle at the air-liquid interface, and published studies commonly use relatively simple vessels and geometries. For example, one recent study cultured K. xylinus statically for seven days before harvesting the resulting pellicles. Therefore, I am assuming that the cultivation environment can be redesigned to provide sufficient oxygen and nutrient access across the 3D former. This would need to be experimentally validated rather than assumed to work immediately. Another assumption is that the BC would probably not be used as a completely standalone structural component. Depending on its mechanical and moisture-management properties, it could ultimately be combined with an elastomer, textile, foam, or other material to create a composite interface. The biological system therefore produces the customized material architecture, while the final orthopedic product would still involve conventional mechanical/product-design components.

3. How would I use automation?

I would use automation primarily during the R&D and optimization stage, and then develop a different automated system for manufacturing. Prototype/R&D: Opentrons liquid-handling robot For early experiments, I would use an Opentrons OT-2 liquid-handling robot. The OT-2 is a programmable benchtop liquid handler capable of performing repetitive liquid-transfer operations and can be controlled through protocols or Python. It can also work with modules such as temperature-control and HEPA systems. I would use it to automate the preparation of many small bacterial-cellulose cultures with different conditions.Instead of manually preparing every experiment, the OT-2 could dispense the required volumes into standardized culture vessels. The goal would therefore be to find a biological manufacturing condition that produces a material suitable for an orthopedic interface, rather than simply the highest possible cellulose yield. The OT-2 is particularly appropriate for this prototyping stage because it is designed for repetitive liquid-handling workflows and supports programmable protocols. Scaling beyond the prototype The OT-2 would not be the machine I would use to manufacture 1,000 full-sized interfaces. At manufacturing scale, I would envision a system consisting of: 3.1. Automated body scan
3.2. automated CAD/former generation 3.3. parallel bioreactors/cultivation chambers 3.4. environmental sensors 3.5. automated harvesting and washing 3.6. dimensional/material inspection The important shift is that the automation changes from automating experiments to automating personalized manufacturing. The cultivation chambers could operate in parallel, with each chamber containing a different patient’s customized former.

4. How much would I need to make?

For a meaningful first manufacturing target, I would define the scale as: 1,000 BioFit orthopedic interfaces This could represent a mixture of knee-brace interfaces and prosthetic-socket interfaces. For simplicity, I will assume that each interface requires approximately 50 g of dry bacterial cellulose. This is an engineering assumption rather than a measured requirement. The actual amount would depend on the final geometry, thickness, whether BC is used alone or as a composite, and the mechanical requirements of the application.

5. How long would manufacturing take?

For a first back-of-the-envelope estimate, I’ll assume that my optimized shaped fermentation system produces approximately: 5 g dry BC/L per production cycle. This is deliberately an engineering assumption rather than a claim about a guaranteed industrial yield, because BC productivity varies substantially with strain, culture medium, reactor configuration and growth conditions. Production conditions and carbon sources are known to substantially influence BC manufacturing. (PubMed Central (PMC)) If I need: 50,000 g then the total culture volume required is: 50,000 g5 g/L=10,000 L So approximately 10,000 L of cumulative culture volume would be required. Suppose each custom liner is grown in a roughly 10 L shaped cultivation chamber. 10 L×5 g/L=50 g That corresponds conveniently to approximately one interface per reactor per cycle. Now assume one growth cycle takes roughly 10 days, followed by approximately 2 days for harvesting, purification, conditioning and QC. So: 12 days/production cycle If a manufacturing facility operates 100 shaped reactors in parallel: 100 liners/cycle For 1,000 liners: 1000100=10 cycles Therefore: 10×12=120 days or approximately: 4 months for 1,000 custom interfaces with 100 parallel cultivation units. Unlike producing one homogeneous chemical in a giant fermentation tank, every BioFit product has different geometry. Scaling therefore means creating a distributed array of individually shaped cultivation chambers, almost like biological 3D printers running simultaneously.

6. What don’t I know yet?

6.1 Can bacterial cellulose actually grow uniformly over a complex 3D form? BC is commonly produced as a pellicle at an air–liquid interface. A residual-limb geometry has vertical surfaces, undercuts and varying curvature.

Can oxygen and nutrients be controlled so that cellulose grows with predictable thickness around an entire 3D former? If not, the cultivation chamber itself needs redesigning.

6.2 Can the material survive the mechanical environment of a prosthesis? A prosthetic interface experiences repeated compression, tension, shear, sweat and thousands of loading cycles. BC has attractive mechanical properties, but that does not automatically mean that pure BC is suitable as a prosthetic liner.

I would need to measure: compression recovery, shear resistance, fatigue life, wet/dry cycling, coefficient of friction and dimensional stability. The outcome may be that BC should become a composite layer combined with an elastomer rather than replace silicone entirely.

6.3 Can moisture management actually be controlled? High water-holding capacity sounds desirable, but in a prosthetic socket it could become either an advantage or a serious disadvantage. If the material absorbs sweat and holds it against the skin, that could worsen maceration rather than solve it. Conversely, engineered pores or channels might transport moisture away from the skin. So one of my main experiments would compare: silicone liner vs. uniform BC vs. patterned/perforated BC for moisture transport, temperature, friction and skin-interface conditions.

AI citation

AI client: ChatGPT, GPT-5.6 Luna, OpenAI. Accessed September 21, 2026.

Prompt: “I am developing a biomanufacturing concept called BioFit — Grown-to-Shape Bacterial Cellulose Prosthetics/Orthotics Interface. The idea is to use Komagataeibacter xylinus to grow a custom bacterial-cellulose interface around a digitally fabricated 3D former derived from a user’s anatomy, for applications including prosthetic sockets and knee braces. Help me develop sections covering the living system, automation, manufacturing scale and time, and the major technical unknowns. Distinguish published information from engineering assumptions and provide sources for important quantitative claims.”

Sources:

https://pubmed.ncbi.nlm.nih.gov/34666147 https://pubmed.ncbi.nlm.nih.gov/31547134 https://pubmed.ncbi.nlm.nih.gov/25356571 https://pubmed.ncbi.nlm.nih.gov/37614406 https://pubmed.ncbi.nlm.nih.gov/42139675 https://opentrons.com/robots